InnoTek Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

InnoTek heeft een totaal eigen vermogen van SGD174.1M en een totale schuld van SGD9.0M, wat de schuld-eigenvermogensverhouding op 5.2% brengt. De totale activa en totale passiva bedragen respectievelijk SGD278.1M en SGD104.0M. De EBIT InnoTek is SGD4.0M waardoor de rentedekking 18.9 is. Het heeft contanten en kortetermijnbeleggingen van SGD64.9M.

Belangrijke informatie

5.2%

Verhouding schuld/eigen vermogen

S$9.00m

Schuld

Rente dekkingsratio	18.9x
Contant	S$64.93m
Aandelen	S$174.09m
Totaal verplichtingen	S$104.03m
Totaal activa	S$278.12m

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Shareholders May Be Wary Of Increasing InnoTek Limited's (SGX:M14) CEO Compensation Package

Apr 21

InnoTek Limited's (SGX:M14) Intrinsic Value Is Potentially 43% Above Its Share Price

Mar 05

Is There More Growth In Store For InnoTek's (SGX:M14) Returns On Capital?

Feb 20

Does InnoTek Limited (SGX:M14) Have A Place In Your Dividend Portfolio?

Feb 01

Do Insiders Own Lots Of Shares In InnoTek Limited (SGX:M14)?

Jan 21

Is It Too Late To Consider Buying InnoTek Limited (SGX:M14)?

Jan 08

How Much Did InnoTek's (SGX:M14) CEO Pocket Last Year?

Dec 22

InnoTek Limited's (SGX:M14) Intrinsic Value Is Potentially 98% Above Its Share Price

Dec 04

InnoTek (SGX:M14) Has Gifted Shareholders With A Fantastic 286% Total Return On Their Investment

Nov 19

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( SGD194.7M ) M14 } overtreffen de korte termijn passiva ( SGD92.4M ).

Langlopende schulden: De kortetermijnactiva M14 ( SGD194.7M ) overtreffen de langetermijnschulden ( SGD11.6M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: M14 heeft meer geld in kas dan de totale schuld.

Schuld verminderen: De schuld/eigen vermogen-ratio van M14 is de afgelopen 5 jaar gestegen van 0% naar 5.2%.

Schuldendekking: De schuld van M14 wordt goed gedekt door de operationele kasstroom ( 164.2% ).

Rentedekking: De rentebetalingen op de schuld van M14 worden goed gedekt door EBIT ( 18.9 x dekking).

InnoTek Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Recent updates

First half 2024 earnings released: EPS: S$0.014 (vs S$0.015 in 1H 2023)

New minor risk - Profit margin trend

InnoTek Limited Announces Appointment of Tan Siang Keng, Angeline as Group Chief Financial Officer

InnoTek Limited Announces Appointment of Ng Hin Lee as Non-Executive and Independent Director

Shareholders May Be Wary Of Increasing InnoTek Limited's (SGX:M14) CEO Compensation Package

InnoTek's (SGX:M14) Performance Is Even Better Than Its Earnings Suggest

Full year 2023 earnings released: EPS: S$0.02 (vs S$0.01 in FY 2022)

Dividend of S$0.02 announced

InnoTek Limited's (SGX:M14) Shares May Have Run Too Fast Too Soon

InnoTek Limited, Annual General Meeting, Apr 26, 2024

Innotek Limited Announces Executive Changes

InnoTek Limited to Report Fiscal Year 2023 Results on Feb 29, 2024

Full year 2023 earnings released: EPS: S$0.019 (vs S$0.01 in FY 2022)

Now 20% overvalued after recent price rise

Now 20% overvalued after recent price rise

First half 2023 earnings released: EPS: S$0.015 (vs S$0.007 loss in 1H 2022)

InnoTek Limited Approves One-Tier Tax-Exempt First and Final Dividend for the Year Ended 31 December 2022

Upcoming dividend of S$0.02 per share at 4.2% yield

Full year 2022 earnings released: EPS: S$0.01 (vs S$0.05 in FY 2021)

Full year 2022 earnings released: EPS: S$0.01 (vs S$0.05 in FY 2021)

InnoTek Limited Announces the Resignation of Ms. Sim Hwee Ai as Company Secretary

First half 2022 earnings released

InnoTek Limited Provides Group Earnings Guidance for the Six Months Ended June 30, 2022

InnoTek Limited Proposes Tax Exempted (1-Tier) First and Final Dividend, Payable on 25 May 2022

Price target increased to S$1.20

Full year 2021 earnings: EPS and revenues miss analyst expectations

InnoTek Limited, Annual General Meeting, Apr 28, 2022

Key Executive exercised options to buy S$1.8m worth of stock.

The Returns On Capital At InnoTek (SGX:M14) Don't Inspire Confidence

InnoTek Limited Proposes Final One-Tier Tax Exempt Dividend for the Financial Year 2021

Full year 2021 earnings: EPS and revenues miss analyst expectations

CFO & Corporate Controller Siew Hoon Quek has left the company

Finance Director of Mansfield Group Meow Khim Neo has left the company

InnoTek (SGX:M14) Is Looking To Continue Growing Its Returns On Capital

Upcoming dividend of S$0.02 per share

Full year 2020 earnings released: EPS S$0.061 (vs S$0.074 in FY 2019)

At S$0.80, Is It Time To Put InnoTek Limited (SGX:M14) On Your Watch List?

Did You Participate In Any Of InnoTek's (SGX:M14) Incredible 476% Return?

InnoTek Limited's (SGX:M14) Intrinsic Value Is Potentially 43% Above Its Share Price

Is There More Growth In Store For InnoTek's (SGX:M14) Returns On Capital?

New 90-day high: S$0.73

Does InnoTek Limited (SGX:M14) Have A Place In Your Dividend Portfolio?

Do Insiders Own Lots Of Shares In InnoTek Limited (SGX:M14)?

Key Executive exercised options to buy S$1.3m worth of stock.

Is It Too Late To Consider Buying InnoTek Limited (SGX:M14)?

New 90-day high: S$0.57

How Much Did InnoTek's (SGX:M14) CEO Pocket Last Year?

New 90-day high: S$0.57

InnoTek Limited's (SGX:M14) Intrinsic Value Is Potentially 98% Above Its Share Price

InnoTek (SGX:M14) Has Gifted Shareholders With A Fantastic 286% Total Return On Their Investment

New 90-day high: S$0.49

New 90-day high: S$0.45

New 90-day high - S$0.41

Earnings released

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven